Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet M Allen

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Pediatric Diabetes|April 30, 2025
Sleep Quality and Quantity in Caregivers of Children with Type 1 Diabetes Using Closed-Loop Insulin Delivery or a Sensor-Augmented PumpJuan J Madrid-Valero, Julia Ware, Janet M Allen, et al.
Diabetes Care|June 26, 2014
Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover studyLalantha Leelarathna, Sibylle Dellweg, Julia K Mader, et al.
Diabetes Care|June 26, 2024
Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized TrialJulia Ware, Charlotte K Boughton, Janet M Allen, et al.
Journal of Diabetes Science and Technology|October 14, 2024
Closed-Loop Therapy and Sleep in Young People Newly Diagnosed With T1D and Their ParentsJuan J Madrid-Valero, Eleanor M Scott, Charlotte K Boughton, et al.
BMJ Open|June 6, 2019
Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocolGianluca Musolino, Janet M Allen, Sara Hartnell, et al.
The Lancet. Diabetes & Endocrinology|June 20, 2014
Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover studyHood Thabit, Alexandra Lubina-Solomon, Marietta Stadler, et al.
Diabetes Technology & Therapeutics|August 5, 2015
Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living ConditionsHood Thabit, Lalantha Leelarathna, Malgorzata E Wilinska, et al.
BMJ Open|February 13, 2021
Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocolJulia Fuchs, Janet M Allen, Charlotte K Boughton, et al.
Lancet (London, England)|October 8, 2018
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trialMartin Tauschmann, Hood Thabit, Lia Bally, et al.
BMJ Open|March 15, 2020
Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocolCharlotte Boughton, Janet M Allen, Martin Tauschmann, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Pediatric Diabetes|April 30, 2025
Sleep Quality and Quantity in Caregivers of Children with Type 1 Diabetes Using Closed-Loop Insulin Delivery or a Sensor-Augmented PumpJuan J Madrid-Valero, Julia Ware, Janet M Allen, et al.
Diabetes Care|June 26, 2014
Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover studyLalantha Leelarathna, Sibylle Dellweg, Julia K Mader, et al.
Diabetes Care|June 26, 2024
Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized TrialJulia Ware, Charlotte K Boughton, Janet M Allen, et al.
Journal of Diabetes Science and Technology|October 14, 2024
Closed-Loop Therapy and Sleep in Young People Newly Diagnosed With T1D and Their ParentsJuan J Madrid-Valero, Eleanor M Scott, Charlotte K Boughton, et al.
BMJ Open|June 6, 2019
Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocolGianluca Musolino, Janet M Allen, Sara Hartnell, et al.
The Lancet. Diabetes & Endocrinology|June 20, 2014
Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover studyHood Thabit, Alexandra Lubina-Solomon, Marietta Stadler, et al.
Diabetes Technology & Therapeutics|August 5, 2015
Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living ConditionsHood Thabit, Lalantha Leelarathna, Malgorzata E Wilinska, et al.
BMJ Open|February 13, 2021
Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocolJulia Fuchs, Janet M Allen, Charlotte K Boughton, et al.
Lancet (London, England)|October 8, 2018
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trialMartin Tauschmann, Hood Thabit, Lia Bally, et al.
BMJ Open|March 15, 2020
Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocolCharlotte Boughton, Janet M Allen, Martin Tauschmann, et al.
Pageof 9